Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | AMGN | GILD | BIIB | CELG |
| Company | Catabasis Pharma | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.21 | 272.14 | 67.09 | 193.34 | 108.01 |
| High | 9.21 | 274.48 | 67.68 | 195.86 | 108.59 |
| Low | 8.46 | 271.05 | 67.00 | 192.75 | 107.27 |
| Last | 8.54 | 273.64 | 67.03 | 193.18 | 108.24 |
| Change | -0.64 | +1.73 | +0.08 | -0.93 | +0.11 |
| % Change | -6.97% | +0.64% | +0.12% | -0.48% | +0.10% |
| Volume | 98,800 | 2,492,537 | 5,219,538 | 1,437,441 | 191,230,496 |
| 20-Day Average Volume | 395,311 | 2,173,723 | 6,228,471 | 1,158,492 | 16,188,930 |
| Previous Close | 9.18 | 271.91 | 66.95 | 194.11 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 271.99 | 69.35 | 202.66 | 108.17 |
| 20-Day Raw Stochastic | 56.46% | 46.01% | 16.88% | 12.99% | 63.25% |
| 20-Day Relative Strength | 43.24% | 48.66% | 34.03% | 31.54% | 64.69% |
| Weighted Alpha | -50.43 | +11.43 | -20.51 | -38.61 | +46.30 |
| Today's Opinion | 88% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 72% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +2.96% since 04/16/24 | -0.10% since 04/16/24 | -1.05% since 04/16/24 | -1.97% since 11/13/19 |
| Low | 8.46 on 09/08/21 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 10.26 on 09/02/21 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 196.77 on 04/22/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -0.96% since 03/22/24 | -7.39% since 03/22/24 | -11.46% since 03/22/24 | +5.14% since 10/18/19 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 10.26 on 09/02/21 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -11.75% since 01/23/24 | -15.39% since 01/23/24 | -23.28% since 01/23/24 | +13.63% since 08/20/19 |
| Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 15.72 on 06/16/21 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | +0.16% since 10/23/23 | -13.30% since 10/23/23 | -23.80% since 10/23/23 | +14.14% since 05/20/19 |
| Low | 6.31 on 08/20/21 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 22.01 on 03/18/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 145,845,984 | 83,357,904 | 28,216,022 | 77,035,920 |
| Shares Outstanding, K | 3,904 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -37,300,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -7,470,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.66 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 08/09/21 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 13.20 | 10.99 |